scholarly article | Q13442814 |
P50 | author | Jiuwei Cui | Q88018392 |
P2093 | author name string | Wei Li | |
Hong Wang | |||
Andrew R Hoffman | |||
Guanjun Wang | |||
Xue Wen | |||
Ji-Fan Hu | |||
Dehai Yu | |||
Yunpeng Sun | |||
Jingnan Sun | |||
P2860 | cites work | Long noncoding RNA as modular scaffold of histone modification complexes | Q22065890 |
An antisense RNA regulates the bidirectional silencing property of the Kcnq1 imprinting control region | Q24563030 | ||
Transcriptional interference--a crash course | Q24606100 | ||
Silencing by imprinted noncoding RNAs: is transcription the answer? | Q24610022 | ||
Capturing chromosome conformation | Q28201750 | ||
The non-coding Air RNA is required for silencing autosomal imprinted genes | Q28504980 | ||
Epigenetic regulation by long noncoding RNAs | Q29618108 | ||
Poised transcription factories prime silent uPA gene prior to activation. | Q33522209 | ||
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody | Q33707416 | ||
Competition--a common motif for the imprinting mechanism? | Q33887777 | ||
Characterization of the RNA content of chromatin | Q33940935 | ||
Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming. | Q34037100 | ||
Chromosomal silencing and localization are mediated by different domains of Xist RNA. | Q34108304 | ||
The proliferating role of insulin and insulin-like growth factors in cancer | Q34172625 | ||
X chromosome inactivation is mediated by Xist RNA stabilization | Q34439255 | ||
Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum | Q34599474 | ||
In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin | Q34606712 | ||
Insulin-like growth factor system and sporadic malignant melanoma. | Q34756364 | ||
The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus | Q34776140 | ||
Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II. | Q34918219 | ||
The emerging role of RNA in the regulation of gene transcription in human cells | Q35089611 | ||
The inactive X chromosome adopts a unique three-dimensional conformation that is dependent on Xist RNA. | Q35098579 | ||
Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation. | Q35120698 | ||
Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming | Q35130964 | ||
High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling | Q35208383 | ||
Regulation of insulin preRNA splicing by glucose | Q36130429 | ||
Two distinct mechanisms of silencing by the KvDMR1 imprinting control region | Q36392021 | ||
Imprinting of the mouse Igf2r gene depends on an intronic CpG island. | Q52184971 | ||
Imprinted expression of the Igf2r gene depends on an intronic CpG island. | Q52192434 | ||
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma | Q62016691 | ||
α-Amanitin: A specific inhibitor of one of two DNA-dependent RNA polymerase activities from calf thymus | Q69901208 | ||
Specific Inhibition of Nuclear RNA Polymerase II by α-Amanitin | Q69917178 | ||
The insulin-like growth factor 1 receptor gene is normally biallelically expressed in human juvenile tissue and tumours | Q72250018 | ||
Human insulin-like growth factor type I and type II receptors are not imprinted | Q72250045 | ||
Insulin-like growth factor I is a dual effector of multiple myeloma cell growth | Q73053018 | ||
Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia | Q79734958 | ||
Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing | Q85652146 | ||
A complex deoxyribonucleic acid looping configuration associated with the silencing of the maternal Igf2 allele | Q36710170 | ||
Long noncoding RNAs: cellular address codes in development and disease | Q36837377 | ||
The human imprintome: regulatory mechanisms, methods of ascertainment, and roles in disease susceptibility | Q36931989 | ||
Higher order chromatin structure at the X-inactivation center via looping DNA. | Q36936154 | ||
CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop | Q36959918 | ||
Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts | Q37158599 | ||
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor | Q37215171 | ||
Genomic imprinting: employing and avoiding epigenetic processes | Q37362832 | ||
Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro | Q37389178 | ||
Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus. | Q37441308 | ||
Targeting the insulin-like growth factor network in cancer therapy | Q37839580 | ||
Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer | Q37859024 | ||
No-nonsense functions for long noncoding RNAs | Q37865710 | ||
Blockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancers | Q37903356 | ||
Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review | Q37904188 | ||
Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy | Q37975246 | ||
The insulin and insulin-like growth factor receptor family in neoplasia: an update | Q37984217 | ||
Targeting insulin-like growth factor in breast cancer therapeutics | Q37994382 | ||
The role of the insulin-like growth factor-I receptor in malignancy: an update | Q38055534 | ||
Structure and function of long noncoding RNAs in epigenetic regulation | Q38086776 | ||
Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cells | Q39084351 | ||
Transcriptional silencing by hairpin RNAs complementary to a gene promoter | Q39330560 | ||
Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture | Q40027528 | ||
Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway | Q40117414 | ||
Gametic imprinting in mammals | Q40383353 | ||
Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors | Q40560633 | ||
Lack of reciprocal genomic imprinting of sense and antisense RNA of mouse insulin-like growth factor II receptor in the central nervous system | Q41645080 | ||
Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops | Q42632085 | ||
Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs | Q42677869 | ||
Survival of acute myeloid leukemia cells requires PI3 kinase activation | Q44408364 | ||
PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways | Q45259661 | ||
Differential biallelic activation of three insulin-like growth factor II promoters in the mouse central nervous system. | Q45962552 | ||
Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation. | Q45985336 | ||
Tissue-specific imprinting of the mouse insulin-like growth factor II receptor gene correlates with differential allele-specific DNA methylation | Q46044781 | ||
Allele-specific histone acetylation accompanies genomic imprinting of the insulin-like growth factor II receptor gene | Q46986615 | ||
Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. | Q48125063 | ||
A differentially methylated region within the gene Kcnq1 functions as an imprinted promoter and silencer | Q48262708 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 9588-9601 | |
P577 | publication date | 2014-08-04 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | A novel antisense long noncoding RNA within the IGF1R gene locus is imprinted in hematopoietic malignancies | |
P478 | volume | 42 |
Q36774935 | A long non-coding RNA interacts with Gfra1 and maintains survival of mouse spermatogonial stem cells |
Q60045651 | A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1 |
Q36375083 | A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer |
Q94526828 | Aberrant LncRNA Expression in Leukemia |
Q99630180 | Aberrant allelic-switch of antisense lncRNA IRAIN may be an early diagnostic marker in laryngeal cancer |
Q35846233 | Antitumor potential of a synthetic interferon-alpha/PLGF-2 positive charge peptide hybrid molecule in pancreatic cancer cells |
Q33798311 | CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors |
Q26772020 | Characteristics of Antisense Transcript Promoters and the Regulation of Their Activity |
Q26749533 | Clinical significance of microRNAs in chronic and acute human leukemia |
Q59125184 | Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming |
Q38649121 | Comprehensive discovery of noncoding RNAs in acute myeloid leukemia cell transcriptomes |
Q37231371 | DNA Methylation Profiling of Uniparental Disomy Subjects Provides a Map of Parental Epigenetic Bias in the Human Genome |
Q48469386 | DNA Methylation Signatures of Early Childhood Malnutrition Associated With Impairments in Attention and Cognition. |
Q47599561 | Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer |
Q92435023 | Emerging role of long non-coding RNAs in normal and malignant hematopoiesis |
Q55017665 | Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors. |
Q36853857 | Epigenetic suppression of the antitumor cytotoxicity of NK cells by histone deacetylase inhibitor valproic acid |
Q55365672 | Expression levels of long non-coding RNAs are prognostic for AML outcome. |
Q53190281 | Genome-wide characterization of lncRNAs in acute myeloid leukemia. |
Q92424009 | Genome-wide interaction target profiling reveals a novel Peblr20-eRNA activation pathway to control stem cell pluripotency |
Q92709550 | High-throughput screen reveals sRNAs regulating crRNA biogenesis by targeting CRISPR leader to repress Rho termination |
Q38860033 | Histone deacetylase inhibitor valproic acid promotes the induction of pluripotency in mouse fibroblasts by suppressing reprogramming-induced senescence stress |
Q92318158 | Identification of a novel long non-coding RNA within RUNX1 intron 5 |
Q38363814 | Imprinted genes in myeloid lineage commitment in normal and malignant hematopoiesis |
Q35818520 | Inhibition of HIV-1 Viral Infection by an Engineered CRISPR Csy4 RNA Endoribonuclease |
Q33776671 | Knockdown of COPS3 Inhibits Lung Cancer Tumor Growth in Nude Mice by Blocking Cell Cycle Progression |
Q98943915 | LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia |
Q64275121 | Long Non-Coding RNA and Acute Leukemia |
Q38450930 | Long Non-Coding RNAs: New Players in Hematopoiesis and Leukemia |
Q64922153 | Long non-coding RNAs in hematopoietic regulation. |
Q28070169 | Long non-coding RNAs in normal and malignant hematopoiesis |
Q91585001 | Long noncoding RNA IRAIN acts as tumor suppressor via miR-125b in multiple myeloma |
Q90566209 | Long noncoding RNAs and their epigenetic function in hematological diseases |
Q46191604 | Long noncoding RNAs in hematopoietic malignancies |
Q28077492 | Long noncoding RNAs: pivotal regulators in acute myeloid leukemia |
Q37588289 | Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells |
Q55034610 | Lost in translation: The 3'-UTR of IGF1R as an ancient long noncoding RNA. |
Q38434466 | Microarray profiling and co-expression network analysis of the lncRNAs and mRNAs associated with acute leukemia in adults. |
Q33581843 | Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells. |
Q58573068 | Molecular Moirai: Long Noncoding RNA Mediators of HSC Fate |
Q92051398 | Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer |
Q97519235 | Novel Approaches to Profile Functional Long Noncoding RNAs Associated with Stem Cell Pluripotency |
Q47098649 | Novel insights into chromosomal conformations in cancer. |
Q89705407 | Oplr16 serves as a novel chromatin factor to control stem cell fate by modulating pluripotency-specific chromosomal looping and TET2-mediated DNA demethylation |
Q94601237 | Osblr8 orchestrates intrachromosomal loop structure required for maintaining stem cell pluripotency |
Q64929300 | Overexpression of ZEB2-AS1 lncRNA is associated with poor clinical outcomes in acute myeloid leukemia. |
Q58752176 | Parent of origin gene expression in a founder population identifies two new candidate imprinted genes at known imprinted regions |
Q38732979 | Perspectives of long non-coding RNAs in cancer |
Q93188516 | Profiling the epigenetic interplay of lncRNA RUNXOR and oncogenic RUNX1 in breast cancer cells by gene in situ cis-activation |
Q91966794 | Profiling the long noncoding RNA interaction network in the regulatory elements of target genes by chromatin in situ reverse transcription sequencing |
Q38832417 | Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells |
Q64284722 | Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia |
Q90274839 | Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance |
Q55438295 | Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition. |
Q92137481 | The Regulatory Roles of Long Noncoding RNAs in Acute Myeloid Leukemia |
Q97072562 | The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression |
Q90170774 | Three-dimensional genome: developmental technologies and applications in precision medicine |
Q37616010 | Understanding of leukemic stem cells and their clinical implications. |
Q38815636 | Valproic Acid Enhances iPSC Induction From Human Bone Marrow-Derived Cells Through the Suppression of Reprogramming-Induced Senescence |
Q89143778 | lncRNA TNXA-PS1 Modulates Schwann Cells by Functioning As a Competing Endogenous RNA Following Nerve Injury |
Search more.